Key Takeaways:
- AptarGroup, Inc. has introduced its new Beat the Blink™ eye care technology, designed to improve dosing precision and enhance patient experience.
- The technology is part of an exclusive partnership with Bausch and Lomb and is expected to be commercially available within 24 to 36 months.
- Aptar’s portfolio of eye care solutions includes preservative-free multidose systems, ophthalmic squeeze dispensers, and digital healthcare solutions.
- The company’s innovative solutions aim to improve patient experience, safety, and compliance with regulatory requirements.
- Aptar’s partnership approach and suite of services help customers navigate the challenges associated with developing prescription and over-the-counter treatments.
Introduction to Aptar’s Beat the Blink Technology
AptarGroup, Inc., a global leader in drug delivery and consumer product dosing, dispensing, and protection technologies, has announced its new Beat the Blink™ eye care technology. This innovative solution is designed to improve dosing precision and enhance patient experience by "beating the blink" reflex. The technology is currently part of an exclusive partnership with Bausch and Lomb, a leading global eye care company. Beat the Blink is expected to be commercially available within 24 to 36 months, following the completion of development and industrialization.
Features and Benefits of Beat the Blink
The Beat the Blink technology features horizontal drop delivery and formula protection through a tip seal for preservative-free formulations. The design of Beat the Blink is intended to ensure compliance with regulatory and quality requirements for ophthalmic solutions, incorporating a child-resistant concept, new bottle and ventilation design, microbial safety measures, and intended compatibility with a wide range of eye care formulations. This technology aims to address an unmet need in the market by eliminating the need to tilt the head, which may cause targeting errors leading to insufficient administration of eye drops.
Aptar’s Portfolio of Eye Care Solutions
Aptar’s portfolio of eye care solutions includes a range of innovative products, such as the Ophthalmic Squeeze Dispenser (OSD), which is a leading preservative-free multidose eye dropper worldwide. The OSD utilizes a purely mechanical Tip-Seal technology that has been developed for use without preservatives and additives. Aptar also offers Advanced Preservative Free (APF) pumps, which provide microbiological protection and stability for sensitive formulations using purely mechanical means. Additionally, the company’s digital healthcare solutions, including patient monitoring and healthcare management, are designed to improve patient experience and outcomes.
Digital Healthcare Solutions
Aptar’s digital healthcare solutions are designed to be patient-friendly, easy-to-use, and intuitive. These solutions are available as fully integrated technologies or extensions and can be used for the prevention, diagnosis, and treatment of diseases. The company’s digital healthcare solutions for eye care are designed to improve patient experience, safety, and compliance with regulatory requirements. Aptar’s partnership approach and suite of services help customers navigate the challenges associated with developing prescription and over-the-counter treatments.
About Aptar
Aptar is a global leader in drug delivery and consumer product dispensing, dosing, and protection technologies. The company serves a number of attractive end markets, including pharmaceutical, beauty, food, beverage, personal care, and home care. With over 13,000 dedicated employees in 20 countries, Aptar is headquartered in Crystal Lake, Illinois. The company’s mission is to make a meaningful difference in the lives, looks, health, and homes of millions of patients and consumers around the world.
Conclusion
In conclusion, Aptar’s Beat the Blink technology is a significant innovation in the eye care industry, designed to improve dosing precision and enhance patient experience. The company’s portfolio of eye care solutions, including preservative-free multidose systems, ophthalmic squeeze dispensers, and digital healthcare solutions, aims to improve patient experience, safety, and compliance with regulatory requirements. With its partnership approach and suite of services, Aptar is well-positioned to help customers navigate the challenges associated with developing prescription and over-the-counter treatments. As the company continues to innovate and expand its portfolio of eye care solutions, it is likely to make a meaningful difference in the lives of millions of patients and consumers around the world.